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Le´ri-Weill dyschondrosteosis (LWD) is a pseudoautosomal dominant disorder characterized by disproportionate
short stature and a characteristic curving of the radius, known as the “Madelung deformity.” SHOX mutations
resulting in SHOX haploinsufﬁciency have been found in LWD and in a variable proportion of patients with
idiopathic short stature (ISS), whereas homozygous loss of SHOX results in the more severe Langer mesomelic
dysplasia (LMD). Defects in SHOX have been identiﬁed in ∼60% of LWD cases, whereas, in the remaining ∼40%,
the molecular basis is unknown. This suggests either genetic heterogeneity or the presence ofmutations in unanalyzed
regions of SHOX, such as the upstream, intragenic, or downstream regulatory sequences. Therefore, the pseudo-
autosomal region 1 (PAR1) of 80 patients with LWD, in whom SHOX deletions and mutations had been excluded,
was screened for deletions by use of a new panel of microsatellite markers. We identiﬁed 12 patients with LWD
who presented with a novel class of PAR1 deletions that did not include SHOX. The deletions were of variable
size and mapped at least ∼30–530 kb downstream of SHOX. In our cohort, this type of deletion accounted for
15% of cases. In all cases, the deletions cosegregated with the phenotype. No apparent phenotypic differences were
observed between patients with SHOX deletions and those with this new class of PAR1 deletions. Thus, we present
here the identiﬁcation of a second PAR1 region implicated in the etiopathogenesis of LWD. Our ﬁndings suggest
the presence of distal regulatory elements of SHOX transcription in PAR1 or, alternatively, the existence of an
additional locus apparently involved in the control of skeletal development. Deletion analysis of this newly identiﬁed
region should be included in the mutation screening of patients with LWD, LMD, and ISS.
Introduction
Le´ri-Weill dyschondrosteosis (LWD [MIM 127300]) is
a dominantly inherited skeletal dysplasia character-
ized by disproportionate short stature, mesomelic limb
shortening, and the Madelung deformity of the forearm:
the bowing of the radius and the distal dislocation of
the ulna. Heterozygous deletions or mutations of the
short-stature homeobox-containing gene (SHOX [MIM
312865]) have been identiﬁed as the molecular basis of
LWD (Belin et al. 1998; Shears et al. 1998), whereas
homozygous loss of SHOX results in the more severe
Langer mesomelic dysplasia (LMD [MIM 249700]) (Be-
lin et al. 1998). SHOX is located in the pseudoautosomal
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region 1 (PAR1) of the short arms of the X and Y chro-
mosomes (Ellison et al. 1997; Rao et al. 1997). Thus,
two active copies are required for normal function in
both males and females. It has also been demonstrated
that SHOX haploinsufﬁciency is responsible in part for
the short stature associated with Turner syndrome (El-
lison et al. 1997; Rao et al. 1997; Clement-Jones et al.
2000) and also for a variable proportion (2%–22%) of
cases of idiopathic short stature (ISS) (Rao et al. 1997;
Binder et al. 2000; Rappold et al. 2002; Stuppia et al.
2003; Huber et al. 2004). Those with ISS represent a
heterogeneous group of patients in whom the etiology
of short stature (height !3rd percentile) is undeﬁned.
SHOX encodes a cell-speciﬁc homeodomain protein
involved in cell cycle and growth regulation (Marchini
et al. 2004) that has been shown to act as a transcription
activator in osteogenic cells (Rao et al. 2001), although
its targets have yet to be identiﬁed.
A defect in SHOX has been identiﬁed in ∼60% of
LWD cases, whereas, in the remaining ∼40%, the mo-
lecular basis is still unknown (Schiller et al. 2000; Fal-
cinelli et al. 2002; Flanagan et al. 2002). This suggests
the presence of mutations in previously unanalyzed
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Table 1
Clinical Characteristics of Subjects Who Have LWD with PAR1 Deletions Downstream of SHOX
Family
Sex of
Proband
Proband
Height
(SD)a Clinical Features
No. of
Family Members
Analyzed Nationalityb
1 F .85 Short stature, Madelung 11 Spanish
2 M 2.5 Short stature, Madelung 1 British
3 M ND Short stature, Madelung 4 French
4 F 2.7 Short stature, Madelung 9 British
5 M 2.0 Short stature, no Madelungc 2 French
6 F ND Short stature, Madelung 2 French
7 M 2.5 Short stature, Madelung 3 French
8 F 2.6 Short stature, Madelung 5 French
9 F 3.0 Short stature, Madelung 2 French
10 F .3 Short stature, Madelung 2 French
11 F ND Short stature, no Madelungd 3 French
12 F 4.6 Short stature, Madelung 3 French
NOTE.—All probands are from families with a family history of LWD.
a Standard deviations were corrected for age, sex, and nationality. ND p no data available.
b All probands are of white descent.
c Received diagnosis of LWD because the mother presented with the Madelung deformity.
d Patient was prepubertal at time of diagnosis.
regions, such as the promoters found in the noncoding
exon 1 and part of exon 2 (Blaschke et al. 2003) and/
or intragenic, upstream, and downstream regulatory se-
quences, or, alternatively, the involvement of additional
genes. We therefore screened the PAR1 of 80 patients
with LWD in whom SHOX deletions and mutations
had been excluded, and we identiﬁed a novel class of
PAR1 deletions that lie ∼30–530 kb downstream of
SHOX in 12 patients with LWD. In this cohort, the
frequency of such deletions was 15%. A panel of 25
(18 novel) microsatellites and 41 (10 unreported) SNPs
spanning 650 kb of PAR1 was used to delimit the de-
letion boundaries and to deﬁne a minimal commonly
deleted region. Our results suggest the presence of long-
range regulatory elements of SHOX transcription or,
alternatively, the existence of an additional locus in
PAR1 that, when deleted or mutated, results in a phe-
notype apparently identical to that observed in patients
who have LWD with SHOX mutations or deletions.
Material and Methods
Patients and Controls
Ethical approval was obtained from the respective in-
stitutions. Probands with LWDwere recruited from three
clinics: the genetic clinic at Hopital Necker Enfants
Malades, Paris; the Endocrinology Service at Hospital
Infantil Universitario Nin˜o Jesu´s, Madrid; and the Wes-
sex Regional Genetics Laboratory at Salisbury District
Hospital, United Kingdom. All participants provided in-
formed consent for the studies performed or were di-
agnostic referrals for SHOXmutation testing. Peripheral
blood was drawn from probands and, when possible,
from relevant family members for DNA extraction and,
in some cases, for FISH analysis. The control cohorts
consisted of 50 normal white control individuals and 70
white families. Genomic DNA was isolated from whole
blood by use of the salt-precipitationmethod (Nicolaides
and Stoeckert 1990).
Clinical Evaluation
Clinical details were obtained for all patients recruited
into the study (table 1). Whenever possible, these in-
cluded birth details, actual height and standard deviation
of height according to age and sex, physical examination
of extremities, and the results of X-radiography of the
lower arm. Their family histories were also documented,
including parental heights.
SHOX Genetic Screening
The presence of SHOX whole-gene deletions was
excluded by at least one of the following techniques:
(1) multiplex ligation-dependent probe ampliﬁcation
(MLPA), performed using the SHOX Salsa (MRC-Hol-
land); (2) FISH, with two cosmids covering the entire
SHOX gene; or (3) microsatellite analysis, performed
using markers located intragenically to and 5′ and 3′
ﬂanking the SHOX gene. Analyzed microsatellites in-
cluded previously reported loci, SHOX CA, DYS290,
DXYS233, and DXYS234, and two newly identiﬁed mi-
crosatellites, DXYS10092 and DXYS10093, which are
5′ ﬂanking and intragenic to SHOX, respectively.
The exclusion of point mutations and small deletions
and insertions in SHOX coding sequences and intron/
exon boundaries was done either by direct sequencing
or by denaturing high-performance liquid chroma-
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Table 2
Oligonucleotide Sequences for the Ampliﬁcation
of SHOX Coding Exons and Intron/Exon Boundaries
The table is available in its entirety in the online
edition of The American Journal of Human Genetics.
Table 3
dHPLC Conditions for the Mutation Screening
of SHOX Coding Exons and Intron/Exon Boundaries
The table is available in its entirety in the online
edition of The American Journal of Human Genetics.
tography (dHPLC) (with Transgenomic Wave 3500HT),
and subsequent sequencing of any identiﬁed hetero-
duplex was peformed using the BigDye Terminator V3.1
kit (ABI Biosystems). Further information on primer se-
quences and dHPLC conditions is available in tables 2
and 3.
Design and Genotyping of Microsatellites
The X-chromosome contig (766,173 bp) (National
Center for Biotechnology Information [NCBI] accession
number NT_028413), including the telomeric part of
the PAR1 region, downloaded from the Ensembl Ge-
nome Browser and GenBank Web sites, was used as the
input for the program Tandem Repeats Finder (Benson
1999; see Tandem Repeats Finder Web site). Sequence
positions of microsatellites and SNPs were determined
using Ensembl-listed coordinates. A set of microsatellite
markers was chosen from the output ﬁles by visual ex-
amination, on the basis of the following criteria: (1) unit
size of 2–4 bp, (2) a match of at least 90%, and (3) an
array of six or more copies. Primer pairs were then de-
signed to ﬂank the repeat by use of the program Oligo
6 (Molecular Biology Insights). One primer from each
pair was ﬂuorescently labeled. Primer sequences are
shown in table 4 and are also available at the GDB
Human Genome Database Web site. Initially, new mi-
crosatellites were evaluated using 10 control individuals
to investigate their polymorphic nature; subsequently,
several large families were studied to verify Mendelian
inheritance. Once a marker was shown to exhibit both
variability and Mendelian inheritance, the heterozygos-
ity indices were determined by analyzing at least 100
chromosomes from healthy white control individuals.
The PCR conditions for microsatellite ampliﬁcation
were 1 # Qiagen Hotstart Taq buffer and 1 U of Hot-
start Taq polymerase, 2.0 mM MgCl2, 200 mM dNTPs
(50 mM of each), and 400 nM of each primer. Cycling
conditions were an initial denaturation at 94C for 15
min and 32 cycles at 94C for 30 s, at 50C–57C for
30 s, and at 72C for 40 s, with a ﬁnal extension at
72C for 8 min. Ampliﬁcation products were diluted and
then electrophoresed using an ABI 3100 Sequencer. Al-
lele sizes were determined in relation to internal size
standards (Genescan 400HDRox) by use of Gene-
Mapper 3.5 software (Applied Biosystems).
SNP Analysis
To further delimit the deletion boundaries in regions
for which no microsatellites were predicted and for
which deletion conﬁrmation was required, we identiﬁed
a series of SNPs within the region of interest by using
the dbSNP database at NCBI. Amplicons were designed
to incorporate two or more SNPs. We designed eight
amplicons to encompass 31 known polymorphisms (ta-
ble 5). The SNPs were genotyped by direct sequencing
of the eight amplicons in each proband and family mem-
ber. SNP haplotypes were subsequently determined, to
ﬁnely map the presence of deletions.
To score the SHOXb 657ArG SNP, exon 6b was
ampliﬁed using the sense primer 5′-TGCACTTGGCCT-
TTTTTTTT-3′ and the antisense primer 5′-AGTTCCA-
AGCGATTCTCCTGC-3′. The products were then di-
gested with XmaI (New England Biolabs) and were
scored after electrophoresis on a 4% NuSieve agarose
gel.
FISH Analysis
FISH analysis was performed on metaphase chromo-
somes prepared from peripheral blood lymphocytes by
standard techniques (Pinkel et al. 1986). FISH was
performed with cosmids from the distal PAR1, includ-
ing two that span the entire SHOX gene, 15D10
(LLNOYCO3′M′15D10) and 34F5 (LLNOYCO3′M′34F5)
(Rao et al. 1997), and additional BACs from the En-
sembl tiling path. The centromeric probes DXZ2 and
DYZ3 were used as controls.
Repeat Analysis
In silico examination of repetitive sequences within
the PAR1 contig was performed with the use of the
RepeatMasker program.
Results
Clinical Data
A total of 80 patients with LWD, for whom SHOX
coding-sequence changes and deletions had been ex-
cluded, were screened for novel mutations in the PAR1
sequence ﬂanking SHOX. Twelve patients with LWD
presented with previously undescribed PAR1 deletions
located downstream of SHOX. The pedigrees of the 12
families are depicted in ﬁgure 1. Clinical details of the
probands are summarized in table 1. Of the 12 probands
with LWD, 8 were from families in which dominant
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Table 4
Oligonucleotide Sequences, PCR Conditions, and Amplicon Sizes of the Identiﬁed PAR1 Microsatellites
MICROSATELLITEa
REPEAT
UNIT
OLIGONUCLEOTIDE SEQUENCE
(5′r3′)
ANNEALING
TEMPERATURE
(C)
AMPLICON
SIZE
RANGE
(bp)Sense Antisense
DXYS10092 (GA) TTCGTGACAAAGGCCTTTGC CTACAAGTCCTAGTACCTAC 53 317–367
DXYS10093 (CT) GCCCGTGATCCCAGTACTG CAACTTCCTTGGAAATCTTC 55 233–259
DXYS10090 (TGTT) TGGCTCTCTGAAGGGGCACC CCTGGGTGACAAAGTGACTC 55 195–199
DXYS10091 (AAAC) GAATTGCTTGAACCTGGC AGGGAGGTCATACCTTGTTGAA 55 202–222
DXYS10083 (TG) GGGGGTGTTTGGAAATGGTATAAT TTACAATGTATGTCAGCAGAGACC 51 150–172
DXYS10094 (AT) GGGGCAGACAGAAGACACACAAAAT GCCTGGGCGACAGAGCGAGACTCA 57 221–259
DXYS10095 (CA) GGGAAAGCCTCATATATCTGAC CTGGTGTCTCTCCATTGTCCCCAT 55 229–239
DXYS10085 (TG) AGCCTGTTAGTGCCTCAACTTC GAGTGGCAGCACGTTAATGTCA 54 206–228
DXYS10086 (GAAA) CTGACCCAGACTGTGTCTGAAG AAGGAGATTCCTCAGCAGTGTA 53 135–219
DXYS10087 (CA) TGTGGCCGGGGCAAGATTC CCCCAGCACAATCACTGT 54b 160–196
DXYS10096 (TG) TTTAACAAACCGCATTCTCCAA GTGGTGGAGCTTGCAGTGA 57 240–252
DXYS10088 (TTTA) CAGCCAATCTGTTCAATC CACGCCTATAGTCCCAG 53 266–278
DXYS10089 (TTAT) CGTGCCTGGCTAAGCTGTT GCTGAGGCAGGAGAATCACTTC 54 183–203
DXYS10080 (TG) CCTCTGTGGGACAACATGATA GTTGTGGACAGGACCTCGTTC 56 145–161
DXYS10081 (TTTA) TTCTTGTCGGCTAGTCCTTC TGCCTGTAATCCCAACTACCC 55 267–283
DXYS10082 (CA) TGGTAAGTGCCTGTGG TGTGAACCATAATTCGTAAGA 56 208–222
DXYS10084 (CA) ATTTGAATGTGCACCTCATC TACAAGAAAAGAAGAATCGTG 53 204–222
DXYS10097 (TG) TGAGTGGGATGAGGATGAGA CAAGAGTGAAACTCCATCTC 50 148–176
a Microsatellites are listed in order from telomere to centromere.
b 3.0 mM MgCl2 was added to the PCR reaction.
inheritance of short stature and Madelung deformity
was conﬁrmed by assessment of other family members
and/or was strongly suspected in the previous genera-
tions. Probands 1 and 4 belong to large multigenera-
tional families with a strong family history of short stat-
ure and Madelung deformity, although of variable
severity.
Mutation Analysis of SHOX and the PAR1 Region
PAR1 deletions downstream of SHOX were charac-
terized in 12 families (ﬁg. 2) by use of a panel of 25
microsatellite markers, 18 of which were novel, and 41
SNPs, 10 of which were previously unreported (tables
4–6). In all cases, the presence of two copies of SHOX
was conﬁrmed by microsatellite analysis, MLPA, or
FISH (ﬁg. 3). No point mutation or small deletion or
insertion was detected in the coding exons of SHOX in
any of the probands by dHPLC and DNA sequencing.
In all families, PAR1 deletions cosegregated with the
phenotype (ﬁg. 2). To analyze the incidence of the newly
detected deletions in nonaffected individuals, the PAR1
of 70 control families was also examined by microsat-
ellite analysis. No deletion was observed, which thus
conﬁrmed that the newly detected PAR1 deletions were
not polymorphisms (i.e., not large copy variation). Like-
wise, no deletion was detected in any of the nonaffected
partners or spouses of the probands included in the
study.
Deletion Mapping
The telomeric ends of the deletions were mapped
to ∼30–205 kb downstream of SHOX, between SNP
rs38346966 in amplicon S15 and DXS6796, and the
centromeric ends were mapped to ∼480–530 kb down-
stream, between amplicon S11 and DXS6814. Dele-
tions varied in size from the smallest deletion, detected
in proband 10 and spanning !81 kb from microsatellite
DXYS10086 to possibly amplicon S2, to the largest,
detected in proband 3 and spanning ∼501 kb, from
rs38346966 in amplicon S15 to DXS6814 (ﬁg. 2).
We identiﬁed a null allele at micrrosatelliteDXYS233,
∼270 kb downstream of SHOX, in two-thirds of the
families with deletions (families 1–8). Subsequent screen-
ing of this region with additional microsatellite markers,
18 of which were novel (table 4), revealed the presence
of four additional deletions that did not extend to mi-
crosatellite DXYS233 (families 9–12). Fine mapping of
all 12 deletions enabled us to delimit a minimal com-
monly deleted region of 29 kb, deﬁned distally by mi-
crosatellite DXYS10086 and centromerically by SNP
rs7067102 in amplicon S11. The 5′ limit was determined
from the deletion found in proband 8, whereas the 3′
limit was determined from probands 9 and 10.
Although most of the deletions encompassed multiple
loci, an independent conﬁrmation of the presence of the
deletions was necessary in families 11 and 12 because
their detected deletions encompassed just one informa-
tive microsatellite (ﬁg. 2). Conﬁrmation was obtained
by various means: (1) the designing of alternative pri-
Table 5
Oligonucleotide Sequences and PCR Conditions of the Analyzed PAR1 SNPs
AMPLICON
and dbSNP VARIATION
OLIGONUCLEOTIDE SEQUENCE
(5′r3′)
ANNEALING
TEMPERATURE
(C)
SIZE
(bp)Sense Antisense
S2: GCATTCACACGGTAGTCTTG ATGCCACGCCAGGTATTCTC 54 446
rs5946526 C/G
rs7053485 T/G
S3: TGCAGGGTCTTCAGATAGGTG GCATCTCTTAAAGGGTGGCT 54 680
rs5946342 T/C
rs5988459 C/G
rs5988460 A/G
S4: ACAGACACATCAGTTTCCCTTG GCCAAAGCCCCCTCATTATTAA 55 757
rs5988291 T/G
rs7061267 T/C
rs4504827 T/A
rs4497142 G/T
S6: TCAGCTCACGGCAACG GTTCCTCTTGTCATCTCCC 57 358
rs5946327 A/G
rs5946503 C/A/T
rs5946504 C/T
rs38346958 T/A
rs5946328 G/A
rs5988279 C/T
rs38346959 T/C
rs38346960 T/C
S8: GTAGGTTTCCTGCCGTTTTAG GAGGACGCCAAAGTTCAGGAG 55 530
rs5946518 G/A
rs5946519 G/C
rs5946520 T/G
S11: CAAGTGAGCCAAGTGAGTCG CTTGTCGGTGGGCACAG 56 677
rs38346961 G/C
rs38346962 C/T
rs38346963 T/C
rs38346964 A/G
rs7067102 A/G
rs5946533 C/T
rs7049502 G/C
S14: TCACCTCTCAATGCTGCCATGT GCAGAAGACAGTACCCCTCACC 54a 594
rs6644574 A/G
rs4556269 C/G
rs6644575 C/T
rs1468111 A/G
rs5946759 A/G
rs38346965 C/T
rs5946760 A/G
rs7052082 C/T
S15: CCATCAGAAATGCCTCTCAGAT TAAGCACGTGAGCAGCTATTAA 54 301
rs38346966 G/A
rs5988448 A/T
rs5988449 C/T
rs5988450 C/G
rs5988451 G/A
rs38346967 G/A
a 10% dimethyl sulfoxide (DMSO) was added to the PCR reaction.
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Figure 1 Pedigrees of the 12 families with LWD. The blackened symbols indicate individuals affected with LWD (i.e., Madelung deformity
is present), whereas the gray symbols indicate those with a classiﬁcation of ISS, since no Madelung deformity was observed.
mer pairs for the microsatellite repeat, (2) the exclusion
of polymorphisms below the primers, and (3) SNP anal-
ysis in the ﬂanking regions, to replicate the presence
of a deletion. In family 11, conﬁrmation was obtained
by observing the deletion at SNP rs5946520 in ampli-
con S8, whereas the deletion in family 12 was veriﬁed
using SNPs rs5946327, rs5946503, rs5946328, and
rs5988279 in amplicon S6 and the previously unre-
ported SNP rs38346960. Therefore, in all cases, we were
able to conﬁrm the presence of all identiﬁed deletions
and to delimit their extensions.
Although the precise breakpoint boundaries could not
be determined, our observations suggest the presence of
some hotspots for deletion breakpoints. Five of the 12
families (families 1–3, 5, and 6) have deletions that pos-
sibly share a 5′ limit between the end of SHOX and
amplicon S15, and 3 (families 10–12) have deletions that
share a 5′ limit between DXYS10085 and DXYS10086
(ﬁg. 2). Deletions in families 2, 3, and 6 may share the
same 3′ boundary, betweenmicrosatellitesDXS6814 and
DXYS234; in families 7 and 8, between DXYS10097
and DX6814; and in families 10 and 11, between am-
plicons S8 and S11 (ﬁg. 2).
FISH Analysis
In four probands (of families 1, 2, 4, and 7), FISH
analysis was performed to conﬁrm the presence of a
large-scale hemizygous deletion downstream of SHOX
(ﬁg. 3). A series of cosmids and BACs covering the tar-
geted PAR1 segment were analyzed to determine the
extent of the deletions (ﬁg. 4). The FISH data corrob-
orated the results obtained by microsatellite marker
analysis (ﬁgs. 3 and 4) and conﬁrmed that the deletions
extended to different 5′ and 3′ locations (ﬁg. 4). In ad-
dition, the presence of two hybridization signals with
the overlapping cosmids 15D10 and 34F5, which to-
gether contain the entire SHOX coding sequence (Rao
et al. 1997), conﬁrmed that all four probands had two
copies of SHOX and a heterozygous PAR1 deletion
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Figure 2 Schematic representation of the PAR1 deletion intervals detected using a panel of known and novel microsatellites and SNPs
(not to scale). Microsatellites and amplicons incorporating the SNPs listed in tables 4 and 5 are given above and below the scale bar, respectively.
Markers in bold indicate novel microsatellites.
downstream of SHOX (ﬁgs. 3A and 4). The deletions
were contiguous in all four cases, and the FISH probes
that cover the deleted PAR1 region did not hybridize to
other regions of the genome. Therefore, we can exclude
the occurence of an inversion or translocation of this
region to another part of the X or Y chromosome or to
an autosome.
In family 1, the proband and her unaffected sibling
were investigated by FISH. The results conﬁrmed that
the deletion was present in the affected sibling and was
absent in the unaffected sister, thus validating the seg-
regation pattern observed in the microsatellite analysis
(ﬁg. 3).
Discussion
SHOX mutations have been identiﬁed elsewhere in
∼60% of LWD cases, whereas the genetic defect in the
remaining ∼40% remains unknown (Schiller et al. 2000;
Falcinelli et al. 2002; Flanagan et al. 2002). In our study,
we have identiﬁed the presence of a new class of PAR1
deletions that do not include the SHOX locus, in 12
(15%) of 80 patients with LWD who tested negative
for SHOX mutations or deletions. The deletions were
shown to cosegregate with the phenotype and were ab-
sent in 70 control families. Hence, our results reveal the
existence of a second PAR1 region apparently implicated
in the etiopathogenesis of LWD.
Affected probands displayed characteristic LWD phe-
notypic features indistinguishable from those displayed
by other patients with LWD in whom SHOX deletions
or point mutations were detected. Short stature was
observed in all affected individuals, although the pres-
ence and severity of the Madelung deformity was var-
iable. Interestingly, the presence of PAR1 deletions down-
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Table 6
Heterozygosity Values and Allele Ranges for Novel PAR1
Microsatellite Markers in a Minimum of 100 Chromosomes
from White Control Individuals
Microsatellitea
Repeat
Unit
Heterozygosity
Value
No. of
Observed
Allelesb
DXYS10092 (GA) .96 18
DXYS10093 (CT) .69 14
DXYS10090 (TGTT) .35 3
DXYS10091 (AAAC) .60 3
DXYS10083 (TG) .82 8
DXYS10094 (AT) .67 20
DXYS10095 (CA) .55 6
DXYS10085 (TG) .87 11
DXYS10086 (GAAA) .78 21
DXYS10087 (CA) .68 7
DXYS10096 (TG) .50 6
DXYS10088 (TTTA) .46 4
DXYS10089 (TTAT) .60 4
DXYS10080 (TG) .62 8
DXYS10081 (TTTA) .78 5
DXYS10082 (CA) .73 6
DXYS10084 (CA) .70 9
DXYS10097 (TG) .94 11
a Microsatellites are listed in order from telomere to centromere.
b The number of observed alleles in a cohort of 50 healthy white
individuals. Further information can be found at the GDB Web site.
stream of SHOX were also detected in probands with
short stature and in affected relatives of probands with
LWD who did not display the Madelung deformity—
for example, family 12, in which the same PAR1 de-
letion is associated with a milder degree of affectation
in the father (with short stature) than in the proband
(with short stature and Madelung deformity). Thus, as
described elsewhere for cases in which SHOX deletions
were detected (Schiller et al. 2000), there seems to be a
variable degree of affectation also in carriers of this new
class of PAR1 deletions, probably as a result of sex, age,
and other unknown modifying factors.
Short stature in LWD predominantly arises from a
shortening of the distal bones of the extremities. The
Madelung deformity is the deﬁning feature of LWD and
is represented by a short forearm with bowing of the
radius and distal hypoplasia of the dorsally dislocated
ulna. In general, the severity of the phenotype appears
to increase with age, with much milder effects on stature
and body proportion in childhood. It is also more severe
in females than in males, thus indicating that the pres-
ence of female sex hormones plays an important role
in determining the expression of the clinical phenotype.
However, there are no clear phenotype-genotype cor-
relations, and there is considerable interfamilial varia-
tion (Grigelioniene et al. 2001; the present study). Each
of these factors may complicate diagnosis.
The characterization of a total of 12 different PAR1
deletions by use of a new panel of PAR1 microsatellites
and SNPs revealed that the deleted regions were located
within a range of ∼30–530 kb downstream of the
SHOX 3′ end. Deletions varied in size, from the smallest
at !81 kb to the largest at ∼501 kb. Fine mapping of
all deletions allowed us to delimit a minimal commonly
deleted region of 29 kb, located between microsatellite
DXS6796 and amplicon S11. Both this new class of
PAR1 deletions and the deletions described elsewhere,
encompassing SHOX display genetic heterogeneitywith
regard to location and extent (Schiller et al. 2000;
Schneider et al. 2005; authors’ unpublished data). Nev-
ertheless, there appears to be some clustering of the
breakpoint boundaries, probably as a consequence of
nonhomologous or homologous recombination events.
When we analyzed the contig of interest, which covers
766,173 bp of the PAR1 including SHOX, the overall
percentage of repetitive sequence was found to be 55%,
consistent with that of the overall X chromosome (Ross
et al. 2005). However, a higher incidence of Alu repeats
(28% vs. 8%) and a lower incidence of L1 long inter-
spersed nuclear elements (7% vs. 29%) were found in
this region, compared with the entire X chromosome.
Low-copy repeats favor homologous recombination,
thus predisposing the region to rearrangements (Stan-
kiewicz and Lupski 2002). Indeed, the recombination
fraction seems to be higher (26–38 fold) near the pseu-
doautosomal boundary than at the telomere (Lien et al.
2000; May et al. 2002), for which the recurrent inci-
dence of deletions within this contig, including both
SHOX and the new region of interest, is not unexpected.
Unfortunately, because none of the deletions were de
novo, a detailed investigation of their origin was not
possible.
Two hypotheses may be postulated to explain why
the deletions in this region may result in the LWD phe-
notype: the presence of a second, unknown gene im-
plicated in the pathogenesis of LWD and short stature
or, alternatively, a position effect on SHOX transcrip-
tion. With regard to the ﬁrst hypothesis, we examined,
in each case, the sequence in the vicinity of the deletion-
spanning region for evidence of transcript(s) that might
be interrupted or encompassed by the deletion. No
known transcripts were identiﬁed, but various bioin-
formatically predicted genes were present. Recently, the
DNA sequence of the X chromosome was published by
Ross et al. (2005). On the basis of their predictions,
33% of the X chromosome is transcribed, which is
lower than the recent estimates for autosomes 6, 9, 10,
and 13 (reviewed by Ross et al. [2005]). Consistent with
the low gene density, the frequency of predicted CpG
islands on the X chromosome is 50% below the esti-
mated genome average. The PAR1 region to date con-
sists of 34 known and novel protein-coding genes. Fur-
ther work is therefore required to investigate whether
Figure 3 FISH analyses of proband 1 and her unaffected sister. A, Two copies of SHOX observed as two signals with cosmid 34F5,
which hybridizes to exons 2–6a. B, The deletion observed with cosmid 167H21, which hybridizes to sequences downstream of SHOX.
C, Cosmid 261P4, which maps proximally to the deletion, present as two copies. D, Cosmid 167H21, present as two copies in the unaffected
sister of proband 1. The red signal indicates the pseudoautosomal cosmid/BAC, and the green signal indicates the control probe DXZ2, which
maps to the X centromere.
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Figure 4 Schematic representation of the FISH analysis in probands 1, 2, 4, and 7, by use of a series of PAR1 cosmids and BACs (not
to scale). Microsatellites present in the respective cosmids or BACs are shown above the scale bar. The deletions (D) are represented below the
corresponding cosmids or BACs. dim p diminished FISH signal, which indicates that the sequence was partly deleted and partly normal.
any of these predicted transcripts are expressed and, if
so, to analyze their functional relevance with respect to
the pathogenesis of LWD and short stature.
For an alternative and more likely hypothesis, we can
postulate a positional effect on SHOX transcription.
Evidence supporting the position-effect hypothesis was
previously obtained in a family with LWD carrying a
deletion at microsatellite DXYS233 (Flanagan et al.
2002). Although no further characterization was un-
dertaken to identify the deletion size and breakpoints,
RNA expression analysis of bone-marrow ﬁbroblasts
obtained during corrective physiolysis procedure for the
Madelung deformity revealed the presence of monoal-
lelic expression of the SHOXb transcript (Flanagan et
al. 2002). Although the underlying molecular mecha-
nism remains unclear, the observation by Flanagan et
al. (2002) seems to support the existence of a positional
effect that affects SHOXb expression in association
with the deletion at microsatellite DXYS233.
Gene regulatory elements have the ability tomodulate
gene expression over very long distances and are often
found in gene deserts (Nobrega et al. 2003). Interest-
ingly, the majority of loci associated with position ef-
fects have been described in genes that encode tran-
scription factors involved in development (reviewed by
Kleinjan and van Heyningen [2005]). The mechanism
has been identiﬁed in some cases (reviewed by Kleinjan
and van Heyningen [2005]), but it is often difﬁcult to
assess in human disease because access to the affected
tissues is often impossible.
Further work is needed to identify the factor affected
by these deletions, its role in the etiopathogenesis of
LWD, and its signiﬁcance in the control of skeletal de-
velopment. Point mutations or small deletions or inser-
tions may be present within this unknown factor, which,
along with the identiﬁed deletions, may account for the
remaining ∼40% of patients with LWD in whom no
SHOX mutation or deletion has been identiﬁed.
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In conclusion, we have identiﬁed a novel class of
PAR1 deletions that do not include SHOX in 12 families
with phenotypes fulﬁlling the diagnostic criteria for
LWD. On the basis of our ﬁndings, deletion analysis of
this additional PAR1 locus should be included in the
routine mutation screening of patients for whom LWD,
LMD, or ISS is suspected.
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.ncbi.nlm.nih.gov/Omim/ (for SHOX, LWD, and LMD)
RepeatMasker, http://www.repeatmasker.org/ (for screening
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